Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/22/2012.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-4276-02
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)
- Initial Posting
- 02/22/2012
- Revised Date